1. Home
  2. SBLK vs HAE Comparison

SBLK vs HAE Comparison

Compare SBLK & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Star Bulk Carriers Corp.

SBLK

Star Bulk Carriers Corp.

HOLD

Current Price

$27.15

Market Cap

2.9B

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$67.20

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBLK
HAE
Founded
2006
1971
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.8B
IPO Year
2007
1996

Fundamental Metrics

Financial Performance
Metric
SBLK
HAE
Price
$27.15
$67.20
Analyst Decision
Strong Buy
Buy
Analyst Count
2
9
Target Price
$25.50
$84.13
AVG Volume (30 Days)
1.3M
850.0K
Earning Date
05-20-2026
05-07-2026
Dividend Yield
2.33%
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.05
Revenue
N/A
$910,373,000.00
Revenue This Year
$11.56
N/A
Revenue Next Year
N/A
$5.23
P/E Ratio
$47.06
$32.92
Revenue Growth
N/A
N/A
52 Week Low
$15.84
$47.32
52 Week High
$28.28
$87.32

Technical Indicators

Market Signals
Indicator
SBLK
HAE
Relative Strength Index (RSI) 60.53 70.34
Support Level $25.90 $49.26
Resistance Level $27.45 $86.72
Average True Range (ATR) 0.77 2.94
MACD -0.01 1.42
Stochastic Oscillator 52.31 93.45

Price Performance

Historical Comparison
SBLK
HAE

About SBLK Star Bulk Carriers Corp.

Star Bulk Carriers Corp provides seaborne transportation solutions in the dry bulk sector. The company owns and operates dry bulk carrier vessels, which are used to transport bulk, such as iron ore, coal, grains, bauxite, fertilizers, and steel products. It owns a fleet of vessels that consists of Newcastlemax, Capesize, Post Panamax, Kamsarmax, Panamax, Ultramax, and Supramax. The firm generates the majority of its revenue from Time charters and Voyage charters.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: